Konstantinos Voskarides

Author

University of Cyprus ORCID

Also Known As

K Voskarides, K. Voskarides, KONSTANTINOS VOSKARIDES, Konstantinos Voskarides, Nixon, Brett, Voskarides, Konstantinos

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Cyprus Hippocrateon Private Hospital Nicosia General Hospital Cyprus Institute of Neurology and Genetics Larnaca College

About

Konstantinos Voskarides is an author at University of Cyprus specializing in medicine, pathology, and glomerulonephritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1K
2	Public Health	3	3	198
3	Natural Sciences	2	2	47
4	Biology	2	2	47
5	Biostatistics	1	1	153

Konstantinos Voskarides

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis Daniel P. Gale, Elena Goicoechea de Jorge, H. Terence Cook, The Lancet Glomerular DiseaseGlomerulonephritisComplement SystemAutoimmune DiseaseMedicine	2010	323
COL4A3/COL4A4 Mutations Producing Focal Segmental Glomerulosclerosis and Renal Failure in Thin Basement Membrane Nephropathy Konstantinos Voskarides, Loukas Damianou, Vassos Neocleous, Journal of the American Society of Nephrology Glomerular DiseaseGeneticsRenal PathologyPathologyCypriot Families	2007	210
Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis Alkis Pierides, Konstantinos Voskarides, Yiannis Athanasiou, Nephrology Dialysis Transplantation	2009	157
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics Clint Mizzi, Eleni Dalabira, Judit Kumuthini, PLoS ONE Genetic EpidemiologyGenome-wide Association StudyBiomarker (Medicine)Pharmacogenomics BiomarkersBiostatistics	2016	153
Familial C3 Glomerulopathy Associated with CFHR5 Mutations Yiannis Athanasiou, Konstantinos Voskarides, Daniel P. Gale, Clinical Journal of the American Society of Nephrology	2011	139
Evidence for Activation of the Unfolded Protein Response in Collagen IV Nephropathies Myrtani Pieri, Charalambos Stefanou, Apostolos Zaravinos, Journal of the American Society of Nephrology	2013	86
Frequency of COL4A3/COL4A4 Mutations amongst Families Segregating Glomerular Microscopic Hematuria and Evidence for Activation of the Unfolded Protein Response. Focal and Segmental Glomerulosclerosis Is a Frequent Development during Ageing Louiza Papazachariou, Panayiota Demosthenous, Myrtani Pieri, PLoS ONE	2014	69
Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: The role of Bcl-2 family proteins and ERK1/2 Antigone Lazou, E Iliodromitis, Danuta Cieslak, APOPTOSIS Cardiovascular DiseaseAnaesthetized RabbitsMyocardial InfarctionPhysiologyCardiovascular Pharmacology	2006	54
Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria Konstantinos Voskarides, Maria Arsali, Yiannis Athanasiou, Pediatric Nephrology GlomerulonephritisHemodialysisUrologyRenal FunctionNphs2-r229q Predisposes	2012	54
A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy Gregory Papagregoriou, Kamil Erguler, Harsh Dweep, PLoS ONE	2012	48

Page 1